Publications by Dr Barry King - ePrints

Browsing publications by Dr Barry King.

Newcastle Authors	Title	Year
Dr Joseph Gray Dr Dipanker Chattopadhyay Dr Gary Beale Dr Gillian Patman Dr Luca Miele et al.	A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease	2009
Dr Ellen Hatch Elizabeth Sconce Dr Barry King Dr Hilary Wynne Professor Ann Daly et al.	Polymorphisms in genes associated with the vitamin K epoxide reductase complex do not affect warfarin dose requirement	2007
Professor Ann Daly Dr Barry King	Contribution of CYP2C9 to variability in vitamin K antagonist metabolism	2006
Professor Ann Daly Dr Barry King Julian Leathart	Genotyping for cytochrome P450 polymorphisms	2006
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	[abstract] CYP2C9 polymorphisms and haplotypes: correlation with warfarin dose and metabolism	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Patrick Kesteven Dr Peter Avery et al.	[abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Barry King et al.	The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen	2005
Dr Barry King Dr Pamela MacDonald Dr Dipanker Chattopadhyay Professor Helen Reeves	The Kruppel-like factor 6 tumour suppressor induces apoptosis in HepG2 cells	2005
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Dr Patrick Kesteven Peter Wood et al.	Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin	2004
Professor Ann Daly Dr Barry King	CYP3A5 phenotype-genotype correlations in a British population - Response	2004
Professor Ann Daly Dr Barry King	Genotyping of the A6986G polymorphism of CYP3A5	2004
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Professor Ann Daly Dr Hilary Wynne et al.	The impact of patient age and genetic polymorphism of CYP2C9 on warfarin dose requirements	2004
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	Upstream and coding region CYP2C9 polymorphisms: Correlation with warfarin dose and metabolism	2004
Dr Barry King Julian Leathart Dr Elaine Mutch Professor Faith Williams Professor Ann Daly et al.	CYP3A5 phenotype-genotype correlations in a British population	2003
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	Novel CYP2C9 polymorphisms and their relationship to warfarin dose requirements	2003
Professor Ann Daly Dr Barry King	Pharmacogenetics of oral anticoagulants	2003